THE MICROMERITICS
Online ISSN : 2432-2075
Print ISSN : 0429-9051
ISSN-L : 0429-9051
Business Overview
Cosmetic Business
Hosokawa Micron Cosmetics Corporation
Author information
JOURNAL OPEN ACCESS

2023 Volume 66 Pages 92-93

Details
Abstract

In September 2022, Hosokawa Micron Cosmetics launched the 8th generation hair restorer “Medicated Nano Impact 8”. Currently, we are expanding TV commercials and Internet advertisements nationwide, and have succeeded in cultivating a new customer base. This time, we reviewed the prescription from the beginning and improved the power by optimizing the ingredients. It also includes an environmentally friendly perspective and improvement elements to improve customer usability by changing to environmentally friendly SDGs compatible packages and installing a slit on the side of the container to check the remaining amount.

In addition, with the support of increasing demand and attention to eye care, which is based on wearing a mask, the successor to the eyelash serum “Eyelash Serum” was also released in September 2022. This time, we collaborate with M Saisei Clinic, which specializes in regenerative treatment using stem cells derived from adipocytes. By blending “human fat-derived stem cell conditioned culture medium (hereinafter referred to as stem cell culture medium)”, we have improved the power to those that can be expected to have higher effects in eyelash care.

Under the influence of the new virus worldwide, there are concerns that consumers will not be willing to buy. We will continue to carry out efficient sales promotion activities by taking advantage of mail-order sales that can be purchased even at home. By providing products that utilize the world-class nanoparticle technology of the Hosokawa Micron Group to general consumers, we will continue to study and work every day with our corporate motto to improve the quality of life (QOL) in your social life.

Content from these authors

This article is licensed under a Creative Commons [Attribution 2.1 Japan] license.
https://creativecommons.org/licenses/by/2.1/jp/
Previous article Next article
feedback
Top